白血病

阻断 CD19 CAR-T 细胞上的 CD30 增强其抗 B 细胞白血病/淋巴瘤的功能能力

Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma.

SOHO 最新进展与后续问题 | 外周 T 细胞淋巴瘤：当前格局与新兴问题

SOHO State of the Art Updates and Next Questions | Peripheral T-Cell Lymphoma: Current Landscape and Emerging Questions.

CAR-T 细胞：改善儿童肿瘤结局所缺失的一环？

CAR T cells: the missing piece needed to improve outcomes for children with cancer?

IL-1R 与 NFKBIZ 通路介导间变性大细胞淋巴瘤的免疫调节反应及免疫治疗疗效

The IL-1R and NFKBIZ pathway mediates immunoregulatory responses and immunotherapy efficacy in anaplastic large cell lymphoma.

EB 病毒阳性 T 细胞和 NK 细胞淋巴增殖性疾病：2023 年 SH/EA4HP 淋巴瘤研讨会报告

Epstein-Barr virus-positive T- and NK-cell lymphoproliferative disorders: Report from the 2023 SH/EA4HP Lymphoma Workshop.

EBV+ T 细胞和 NK 细胞 LPDs 的诊断复杂，需结合临床信息及形态学和分子特征的多参数方法。

探索针对人 B 细胞淋巴瘤的 CD19 靶向免疫治疗策略

Exploring CD19-targeted Immunotherapy Strategies for Human B-cell Lymphoma.

种痘样水疱病淋巴增殖性疾病：临床病理与遗传学分析

Hydroa vacciniforme lymphoproliferative disorder, a clinicopathologic and genetic analysis.

SOHO 最新进展与后续问题 | 原发性纵隔 B 细胞淋巴瘤治疗的最新进展

SOHO State of the Art Updates and Next Questions | Latest Advances in the Management of Primary Mediastinal B-Cell Lymphoma.

DESCAR-T 注册登记中 CAR-T 细胞治疗后的 T 细胞恶性肿瘤

T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

γδ T 细胞急性淋巴细胞淋巴瘤/白血病：一种罕见实体的报告

Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity.